The Milner Therapeutics Consortium is excited to launch its fifth call for research proposals! The deadline for applications is 7th March 2025.
Our pharma partners in the Milner Therapeutics Consortium have identified topics for challenges that are a current priority for external collaboration with academics. These projects could provide a better understanding of a disease mechanism or discover and validate new therapeutic targets and can range from reagent sharing and 6-month pilots to 2-year postdoctoral funded collaborations. They are expected to lead to joint publications with the company partners.
Are you an academic at the University of Cambridge, Babraham and Wellcome Sanger Institutes? Do you have an idea for a potential pre-clinical collaborative project that would benefit from industry expertise and know-how? We are looking for project proposals that could provide solutions to current challenges in the following areas, and applications from cross-disciplinary teams are encouraged:
Neuroscience – Immunology & Inflammation – New technologies – Infectious Disease – Reproductive Medicine – Oncology – Metabolism and Cardiovascular disease
Webpage and password
Full details are available on our website. Please note that as this Call is restricted to the University of Cambridge, Babraham and Wellcome Sanger Institutes, the challenge topics webpage is password protected. The password is ConsortiumTopics2025.
Information webinar
To learn more, please register to attend our information and Q&A webinar, taking place on 27th January at 2pm.
Posted on 15/01/2025
